CCND2 and breast cancer: There was a 55% increase in the odds of hypomethylated (vs. hypermethylated) CCND2 promoter‐defined BC (ROR = 1.55, 95% CI = 1.04–2.32; CLR = 2.23) for a one ln‐unit increase in the multiple parabens.